AU2008261550A1 - Method of initiating cardiomyocyte differentiation - Google Patents

Method of initiating cardiomyocyte differentiation Download PDF

Info

Publication number
AU2008261550A1
AU2008261550A1 AU2008261550A AU2008261550A AU2008261550A1 AU 2008261550 A1 AU2008261550 A1 AU 2008261550A1 AU 2008261550 A AU2008261550 A AU 2008261550A AU 2008261550 A AU2008261550 A AU 2008261550A AU 2008261550 A1 AU2008261550 A1 AU 2008261550A1
Authority
AU
Australia
Prior art keywords
cells
csx
stem cells
protein
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008261550A
Other languages
English (en)
Inventor
Mark Alexander Kirkland
Liem Thanh Vo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytomatrix Pty Ltd
Original Assignee
Cytomatrix Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007903204A external-priority patent/AU2007903204A0/en
Application filed by Cytomatrix Pty Ltd filed Critical Cytomatrix Pty Ltd
Priority to AU2008261550A priority Critical patent/AU2008261550A1/en
Publication of AU2008261550A1 publication Critical patent/AU2008261550A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2008261550A 2007-06-14 2008-06-13 Method of initiating cardiomyocyte differentiation Abandoned AU2008261550A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008261550A AU2008261550A1 (en) 2007-06-14 2008-06-13 Method of initiating cardiomyocyte differentiation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2007903204 2007-06-14
AU2007903204A AU2007903204A0 (en) 2007-06-14 Methods
AU2008261550A AU2008261550A1 (en) 2007-06-14 2008-06-13 Method of initiating cardiomyocyte differentiation
PCT/AU2008/000862 WO2008151387A1 (en) 2007-06-14 2008-06-13 Method of initiating cardiomyocyte differentiation

Publications (1)

Publication Number Publication Date
AU2008261550A1 true AU2008261550A1 (en) 2008-12-18

Family

ID=40129149

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008261550A Abandoned AU2008261550A1 (en) 2007-06-14 2008-06-13 Method of initiating cardiomyocyte differentiation

Country Status (3)

Country Link
EP (1) EP2205723A1 (de)
AU (1) AU2008261550A1 (de)
WO (1) WO2008151387A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011139688A2 (en) 2010-04-28 2011-11-10 The J. David Gladstone Institutes Methods for generating cardiomyocytes
EP2750509B1 (de) 2011-08-30 2016-12-28 The J. David Gladstone Institutes Verfahren zur erzeugung von kardiomyozyten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062940A2 (en) * 1998-05-30 1999-12-09 Collateral Therapeutics, Inc. Methods of altering cardiac cell phenotype
US20040126879A1 (en) * 2002-08-29 2004-07-01 Baylor College Of Medicine Heart derived cells for cardiac repair

Also Published As

Publication number Publication date
WO2008151387A1 (en) 2008-12-18
EP2205723A1 (de) 2010-07-14

Similar Documents

Publication Publication Date Title
US20110190730A1 (en) Methods of inducing pluripotency involving oct4 protein
US20110190729A1 (en) Methods of inducing pluripotency involving sox2 protein
Lee et al. Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells
JP5684963B2 (ja) 筋肉由来前駆細胞、その組成物、および治療法を使用した軟部組織および骨の増大および肥厚
JP6817943B2 (ja) 分化転換方法及びその使用方法
US20210145893A1 (en) Compositions to amplify cardiac stem cells in vitro and in viv
SG177467A1 (en) Pre-natal mesenchymal stem cells
WO2009027563A1 (es) Población de células madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneración cardiaca
WO2020198611A1 (en) Highly functional manufactured abcb5+ mesenchymal stem cells
WO2010093655A2 (en) Enhanced method for producing stem-like cells from somatic cells
JP5395672B2 (ja) 心臓病理学を処置するための筋肉由来の細胞およびその作製法および使用法
JP7165979B2 (ja) 骨格筋細胞及びその誘導方法
AU2008261550A1 (en) Method of initiating cardiomyocyte differentiation
US20230212570A1 (en) Cell-penetrating peptide-microrna conjugates for intracellular cell delivery
WO2008151388A1 (en) Methods of initiating insulin production
AU2008263134A1 (en) Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
JP5687059B2 (ja) 筋肉誘導前駆体組成物を利用した骨格筋の強化およびその処置
Tanaka et al. The synthetic peptide SVVYGLR promotes cell motility of myogenic cells and facilitates differentiation in skeletal muscle regeneration
CN110291190B (zh) 骨骼肌细胞及其诱导方法
US20110223138A1 (en) Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins
EP2830639B1 (de) Verfahren und zusammensetzungen unter verwendung von fgf-8 zur verbesserung der regeneration des herzens und zur unterdrückung kardialer remodellierung
JP2022026709A (ja) ＴＧＦ－βを含む組織の線維化抑制剤
WO2011057397A1 (en) Methods for treating or preventing heart damage with integrin-linked kinase (ilk) compositions
JP2009090031A (ja) 自己重合ナノペプチドを用いる心筋幹・前駆細胞移植方法

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period